Eagle Bay Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $210K | Buy |
+2,691
| New | +$210K | 0.17% | 103 |
|
|
2025
Q1 | – | Sell |
-2,691
| Closed | -$199K | – | 397 |
|
|
2024
Q4 | $199K | Sell |
2,691
-49
| -2% | -$3.63K | 0.13% | 113 |
|
|
2024
Q3 | $181K | Sell |
2,740
-550
| -17% | -$36.3K | 0.07% | 186 |
|
|
2024
Q2 | $304K | Hold |
3,290
| – | – | 0.18% | 83 |
|
|
2024
Q1 | $314K | Buy |
3,290
+49
| +2% | +$4.68K | 0.2% | 84 |
|
|
2023
Q4 | $247K | Sell |
3,241
-200
| -6% | -$15.3K | 0.16% | 112 |
|
|
2023
Q3 | $238K | Buy |
3,441
+2,640
| +330% | +$183K | 0.11% | 123 |
|
|
2023
Q2 | $75.6K | Hold |
801
| – | – | 0.04% | 283 |
|
|
2023
Q1 | $66.3K | Hold |
801
| – | – | 0.04% | 323 |
|
|
2022
Q4 | $59.8K | Hold |
801
| – | – | 0.03% | 336 |
|
|
2022
Q3 | $66K | Hold |
801
| – | – | 0.04% | 282 |
|
|
2022
Q2 | $76.2K | Buy |
+801
| New | +$76.2K | 0.05% | 261 |
|
|
2022
Q1 | – | Sell |
-782
| Closed | -$102K | – | 515 |
|
|
2021
Q4 | $102K | Sell |
782
-46
| -6% | -$6K | 0.07% | 173 |
|
|
2021
Q3 | $93K | Buy |
+828
| New | +$93K | 0.05% | 251 |
|